Navigation Links
Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW

been associated with mesalamine medications. In patients with renal impairment, caution should be exercised, and LIALDA should be used only if the benefits outweigh the risks. No information is available for patients with hepatic impairment.

LIALDA is generally well tolerated. The majority of adverse events in the double-blind, placebo-controlled trials were mild or moderate in severity. In clinical trials (n=535), the most common treatment-related adverse events with LIALDA 2.4g/day, 4.8g/day and placebo were headache (5.6 percent, 3.4 percent and 0.6 percent, respectively) and flatulence (four percent, 2.8 percent and 2.8 percent, respectively). Pancreatitis occurred in less than one percent of patients during clinical trials and resulted in discontinuation of therapy with LIALDA.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire's focused strategy is to develop and market products for specialty physicians. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company's website: http://www.shire.com.


    For media inquiries please contact:


    Media            Ashleigh Duchene (GolinHarris)       +1 312 729 4428

                               
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
Post Your Comments:
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... Aug. 31, 2015  On August 5, 2015, the ... Oregon denied motions to dismiss securities class ... ) and certain of its directors. The class actions ... and dump" scheme to artificially inflate Galena,s stock price, ... stock price was inflated, sold massive amounts of their ...
(Date:8/31/2015)... -- Regen BioPharma, Inc. (OTCBB: RGBP) and (PINK: ... of delivering its patented (US Patent 8,263,571) gene ... a clinically approved formulation as delivery system.  The ... silencing therapeutics in which the gene silencing drug ... By utilizing a local delivery system, potential toxicities ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... FREDERICKSBURG, Va., Feb. 17, 2011 Radiologic Associates ... Gently Campaign to increase awareness of opportunities to lower ... initiative of the Alliance for Radiation Safety in Pediatric ... undergone additional training in ways to reduce radiation exposure, ...
... Feb. 17, 2011 The method represented in the ... respiratory arterial pressure wave (a blood wave that ... blood pressure readings to provide healthcare professionals and users ... on systemic blood pressure. (Logo: ...
Cached Medicine Technology:Radiologic Associates of Fredericksburg Announces Image Gently Campaign to 'Child Size' Doses for Children 2ICAP Ocean Tomo Announces Advanced Techniques for Measuring Blood Pressure From Coherence L.L.C. 2
(Date:8/31/2015)... Plains, NJ (PRWEB) , ... August 31, 2015 , ... ... as an “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical and ... orthopedics and traumatic injuries to the entire musculoskeletal system, excluding the spine. , Dr. ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... digital marketing communications company announced today that it has officially launched a new ... the new website and brand refresh are more closely aligned with the company’s ...
(Date:8/31/2015)... ... August 31, 2015 , ... Finnleo is pleased to announce ... Sauna. After months of extensive engineering and design of our newest sauna model, the ... elements and is offered at a very attractive price-point. , Before outdoor saunas ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement (CDI) and medical ... a patent pending ICD-10 solution - ezCAC is an enterprise-level coding solution that ...
(Date:8/31/2015)... Valley, CA (PRWEB) , ... August 31, 2015 , ... ... Ghasri, to the practice. Dr. Pedram Ghasri is a graduate of the University of ... neuroscience and continued his studies at the University of California, Irvine Medical School. As ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2
... of outdated inspection practices desperately needed, critics say ... system that guarantees the safety of food in the ... new report finds. , Gaps in the food safety ... inconsistencies among agencies protecting food safety, according to the ...
... have a significantly higher risk of developing Alzheimers ... remains unexplained. Now, researchers at the Salk Institute ... for the diabetes Alzheimers interaction. , In ... of Neurobiology of Aging, investigators led by David ...
... becoming three kinds of cardiac cells , , WEDNESDAY, April ... created from mouse skin cells reprogrammed to have the ... researchers at the University of California, Los Angeles. ... induced pluripotent stem (iPS) cells, which don,t involve the ...
... Actually Work in Real ... ... healthcare community, announced the launch of an,innovative new tool that brings patient ... drugs, and eight out of,ten surfing the web for their healthcare information, ...
... lifestyles, WASHINGTON, April 29 Blue Cross ... of all sizes to get,their workers to take ... inactive lifestyles and preventable health conditions,have on the ... companies,are holding lunchtime walks across America as part ...
... Inc.,(NYSE: HI ) today announced that its Board ... traded company of $0.1825 per share,on the company,s common ... of record at the close of business on June ... approve this inaugural dividend is based,on the strength of ...
Cached Medicine News:Health News:Report Slams U.S. Food Safety System 2Health News:Report Slams U.S. Food Safety System 3Health News:Report Slams U.S. Food Safety System 4Health News:Salk study links diabetes and Alzheimer's disease 2Health News:Salk study links diabetes and Alzheimer's disease 3Health News:Mouse Skin Cells Reprogrammed to Act Like Embryonic Stem Cells 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 2Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 4Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 5Health News:Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company 2
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
... B3 Triplanar hip joint is ... - extension, abduction - Ad-duction, ... our Boston Post-Op Hip Orthosis. ... custom Hip Spicas in both ...
... advance in walker design in years. A real step ... bearing surfaces of the foot rest on adaptive areas ... heel strike. The footbed in the sole conforms to ... and stability. , ,No leg length discrepancy; Heel ...
... The High Tide walker provides comfortable stability ... of the lower leg, stress fractures of ... fractures of the ankle. Extension pads for ... patients.The shorter Low Tide walker with midcalf ...
Medicine Products: